Some perspectives on dietary inhibition of carcinogenesis: Studies with curcumin and tea

Proceedings of the Society for Experimental Biology and Medicine

Volumn 216, Issue 2, 1997, Pages 234-245

  Conney, A H ^a   Lou, Y R ^a   Xie, J G ^a   Osawa, T ^b   Newmark, H L ^a   Liu, Y ^a   Chang, R L ^a   Huang, M T ^a  

^a RUTGERS UNIVERSITY   (United States)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ACETONE; ARACHIDONIC ACID; BUTYRIC ACID; CAFFEIC ACID; CALCITRIOL; CURCUMIN; FERULIC ACID; LIPOXYGENASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN SYNTHASE; RETINOIC ACID;

ARACHIDONIC ACID METABOLISM; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENESIS; CARCINOGENICITY; COLON CANCER; DIET THERAPY; KERATOACANTHOMA; MOUTH CANCER; REVIEW; TEA; TUMOR GROWTH;

EID: 0030823140     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-216-44173     Document Type: Review

References (112)

1. Richardson HL, Stier AR, Borsos-Nachtnebel E. Liver tumor inhibition and adrenal histologic responses in rats to which 3′-methyl-4-dimethylaminoazobenzene and 20-methylcholanthrene were simultaneously administered. Cancer Res 12:356-361, 1952.
2. Miller EC, Miller JA, Brown RR, MacDonald JC. On the protective action of certain polycyclic aromatic hydrocarbons against carcinogenesis by aminoazo dyes and 2-acetylaminofluorene. Cancer Res 118:469-477, 1958.
3. Conney AH, Miller EC, Miller JA. The metabolism of methylated aminoazo dyes. V. Evidence for induction of enzyme synthesis in the rat by 3-methylcholanthrene. Cancer Res 16:450-459, 1956.
4. Peraino C, Staffeldt EF, Haugen DA, Lombard LS, Stevens FJ, Fry RJ. Effect of varying the dietary concentration of phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis. Cancer Res 40:3268-3273, 1980.
5. Doll R, Peto R. The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 66:1191-1308, 1981.
6. Doll R. The lesson of life: Keynote address to the nutrition and cancer conference. Cancer Res 52(Suppl): 2024S-2029S, 1992.
7. Negri E, La Vecchia C, Franceschi S, D'Avenzo B, Parazzini F. Vegetable and fruit consumption and cancer risk. Int J Cancer 48:350-354, 1991.
8. Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence. Nutr Cancer 18:1-29, 1992.
9. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer. I. Epidemiology. Cancer Causes Control 2:325-357, 1991.
10. Wattenberg LW. Chemoprevention of cancer by naturally occurring and synthetic compounds. In: Wattenberg L, Lipkin M, Boone CW, Kelloff GJ, Eds. Cancer Chemoprevention. Boca Raton, FL: CRC Press, pp19-39, 1992.
11. Wattenberg LW. An overview of chemoprevention: Current status and future prospects. Proc Soc Exp Biol Med 216:133-141, 1997.
12. Sporn MB, Newton DL. Chemoprevention of cancer with retinoids. Fed Proc 38:2528-2534, 1979.
13. Kamm JJ, Dashman T, Conney AH, Burns JJ. Protective effect of ascorbic acid on hepatotoxicity caused by sodium nitrite plus aminopyrine. Proc Natl Acad Sci U S A 70:747-749, 1973.
14. Kamm JJ, Dashman T, Conney AH, Burns JJ. Effect of ascorbic acid on amine-nitrite toxicity. Ann N Y Acad Sci 258:169-174, 1975.
15. Kuenzig W, Chau J, Norkus E, Holowaschenko H, Newmark H, Mergens W, Conney AH. Caffeic and ferulic acid as blockers of nitrosamine formation. Carcinogenesis 5:309-313, 1984.
16. Norkus EP, Kuenzig WA, Chau J, Mergens WJ, Conney AH. Inhibitory effect of α-tocopherol on the formation of nitrosomorpholine in mice treated with morpholine and exposed to nitrogen dioxide. Carcinogenesis 7:357-360, 1986.
17. 1 metabolism in human liver microsomes by naturally occurring flavonoids. Cancer Res 41:67-72, 1981.
18. Wood AW, Huang M-T, Chang RL, Newmark HL, Lehr RE, Yagi H, Sayer JM, Jerina DM, Conney AH. Inhibition of the mutagenicity of bay-region diol epoxides of polycyclic aromatic hydrocarbons by naturally occurring plant phenols: Exceptional activity of ellagic acid. Proc Natl Acad Sci U S A 79: 5513-5517, 1982.
19. Huang M-T, Wood AW, Newmark HL, Sayer JM, Yagi H, Jerina DM, Conney AH. Inhibition of the mutagenicity of bay-region diol epoxides of polycyclic aromatic hydrocarbons by phenolic plant flavonoids. Carcinogenesis 4:1631-1637, 1983.
20. Huang M-T, Chang RL, Wood AW, Newmark HL, Sayer JM, Yagi H, Jerina DM, Conney AH. Inhibition of the mutagenicity of bay-region diol epoxides of polycyclic aromatic hydrocarbons by tannic acid, hydroxylated anthraquinones and hydroxylated cinnamic acid derivatives. Carcinogenesis 6:237-242, 1985.
21. Conney AH. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G.H.A. Clowes Memorial Lecture. Cancer Res 42:4875-4917, 1982.
22. Chopra RN, Chopra IC, Handa KL, Kapur LD. Indigenous Drugs of India (2nd ed). Calcutta: Dhur, pp 325-327, 1958.
23. Nadkarni KM. Curcuma longa. In: Nadkarni KM, Ed. India Materia Medica. Bombay: Popular Prakashan Publishing, pp 414-416, 1976.
24. Sharma OP. Antioxidant activity of curcumin and related compounds. Biochem Pharmacol 25:1811-1812, 1976.
25. Toda S, Miyase T, Arichi H, Tanizawa H, Takino Y. Natural antioxidants. III. Antioxidative components isolated from rhizome of Curcuma longa L. Chem. Pharm Bull (Tokyo) 33:1725-1728, 1985.
26. Srimal RC, Dhawan BN. Pharmacology of diferuloyl methane (curcumin), a nonsteroidal anti-inflammatory agent. J Pharm Pharmacol 25:447-452, 1973.
27. Rao TS, Basu N, Siddiqui HH. Anti-inflammatory activity of curcumin analogues. Indian J Med Res 75:574-578, 1982.
28. Mukhopadhyay A, Basu N, Ghatak N, Gujral PK. Anti-inflammatory and irritant activities of curcumin analogues in rats. Agents Actions 12:508-515, 1982.
29. Yegnanarayan R, Saraf AP, Balwani JH. Comparison of anti-inflammatory activity of various extracts of Curcuma longa (Linn). Indian J Med Res 64:601-608, 1976.
30. Huang M-T, Smart RC, Wong C-Q, Conney AH. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 48:5941-5946, 1988.
31. Huang M-T, Wang ZY, Georgiadis CA, Laskin JD, Conney AH. Inhibitory effects of curcumin on tumor initiation by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene. Carcinogenesis 13:2183-2186, 1992.
32. Huang M-T, Lysz T, Ferraro T, Conney AH. Inhibitory effects of curcumin on tumor promotion and arachidonic acid metabolism in mouse epidermis. In: Wattenberg L, Lipkin M, Boone CW, Kelloff GJ, Eds. Cancer Chemoprevention. Boca Raton, FL: CRC Press, pp375-391, 1992.
33. Lu YP, Chang RL, Huang M-T, Conney AH. Inhibitory effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced increase in ornithine decarboxylase mRNA in mouse epidermis. Carcinogenesis 14:293-297, 1993.
34. Huang M-T, Ma W, Yen P, Xie J-G, Han J, Frenkel K, Grunberger D, Conney AH. Inhibitory effects of topical application of low doses of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and oxidized DNA bases in mouse epidermis. Carcinogenesis 18:83-88, 1997.
35. Weiss LC. Report on chlorogenic acid in coffee. J Assoc Official Agricul Chem (JAOAC) 40:350-354, 1957.
36. Huang M-T, Ma W, Lu Y-P, Chang RL, Fisher C, Manchand PS, Newmark HL, Conney AH. Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion. Carcinogenesis 16:2493-2497, 1995.
37. Huang M-T, Ma W, Yen P, Xie J-G, Han J, Frenkel K, Grunberger D, Conney AH. Inhibitory effects of caffeic acid phenethyl ester (CAPE) on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in mouse skin and the synthesis of DNA, RNA, and protein in HeLa cells. Carcinogenesis 17:761-765, 1996.
38. Pabon HJJ. A synthesis of curcumin and related compounds. Rec Trav Chim Pays-Bas 379-386, 1964.
39. Sreejayan N, Rao MNA. Curcuminoids as potent inhibitors of lipid peroxidation. J Pharm Pharmacol 46:1013-1016, 1994.
40. Osawa T, Ramarathnam N, Kawakishi S, Namiki M. Antioxidative defense systems generated by phenolic plant constituents. In: Huang M-T, Ho C-T, Lee CY, Eds. Phenolic Compounds in Food and Their Effects on Health II. Antioxidants and Cancer Prevention. Washington, DC: American Chemical Society Symposium, Series 507: pp122-134, 1992.
41. Osawa T, Sugiyama Y, Inayoshi M, Kawakishi S. Antioxidative activity of tetrahydrocurcuminoids. Biosci Biotech Biochem 59:1609-1612, 1995.
42. Sugiyama Y, Kawakishi S, Osawa T. Involvement in the β-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin. Biochem Pharmacol 52:519-525, 1996.
43. Tanaka T, Makita H, Ohnishi M, Hirose Y, Wang A, Mori H, Satoh K, Hara A, Ogawa H. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperidin: Comparison with the protective effect of β-carotene. Cancer Res 54:4653-4659, 1994.
44. Huang M-T, Lou Y-R, Ma W, Newmark HL, Reuhl KR, Conney AH. Inhibitory effects of dietary curcumin on forestomach, duodenal and colon carcinogenesis in mice. Cancer Res 54:5841-5847, 1994.
45. Rao C, Rivenson RA, Simi B, Reddy BS. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compounds. Cancer Res 55:259-266, 1995.
46. Kato R, Nakadate T, Yamamoto S, Sugimura T. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and ornithine decarboxylase activity by quercetin: Possible involvement of lipoxygenase inhibition. Carcinogenesis (Lond) 4:1301-1305, 1983.
47. Nakadate T, Yamamoto S, Ishii M, Kato R. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity by lipoxygenase inhibitors: Possible role of product(s) of lipoxygenase pathway. Carcinogenesis (Lond) 3:1411-1414, 1982.
48. Fischer SM, Mills GD, Slaga TJ. Inhibition of mouse skin tumor promotion by several inhibitors of arachidonic acid metabolism. Carcinogenesis (Lond) 3:1243-1245, 1982.
49. Flynn DL, Rafferty MF, Boctor AM. Inhibition of 5-hydroxyeicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally occurring diarylheptanoids: Inhibitory activities of curcuminoids and yakuchinones. Prostaglandins Leukot Med 22:357-360, 1986.
50. Huang M-T, Lysz T, Ferraro T, Abidi TF, Laskin JD, Conney AH. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res 51:813-819, 1991.
51. 4. Cancer Res 49:1138-1142, 1989.
52. Avis IM, Jet M, Boyle T, Vos MD, Moody T, Treston AM, Martinex A, Mulshine JL. Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling. J Clin Invest 97:806-813, 1996.
53. Reddy BS, Tokumo K, Kulkarni N, Aligia C, Kelloff G. Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds. Carcinogenesis (Lond) 13:1019-1023, 1992.
54. Karmali R. Prostaglandins and cancer. CA Cancer J Clin 33:322-332, 1983.
55. Earnest D, Hixson L, Fennerty MB, Emerson SS, Alberts DS. Inhibition of prostaglandin synthesis: Potential for chemoprevention of human colon cancer. Cancer Bull 43:561-568, 1991.
56. Neoptolemos JP, Husband D, Imray C, Rowley S, Lawson N. Arachidonic acid and docosahexaenoic acid are increased in human colorectal cancer. Gut 32:278-281, 1991.
57. Marnett LJ. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 52:5575-5589, 1992.
58. Thun MJ, Namboodiri MM, Heath CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325:1593-1596, 1991.
59. Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations, and medications: Case control results from the Melbourne Colorectal Cancer Study. Cancer Res 48:4399-4404, 1988.
60. Waddell WR, Loughry RW. Sulindac for polyposis of the colon. J Surg Oncol 24:83-87, 1983.
61. Waddell WR, Gasner GF, Cerise EJ, Loughry RW. Sulindac for polyposis of colon. Am J Surg 157:175-178, 1989.
62. Hixson LJ, Alberts DS, Krutzsch M, Einsphar J, Brendel K, Gross PH, Paranka NS, Baier M, Emerson S, Pamukcu R, Burt RW. Anti-proliferative effect of nonsteroidal antiinflammatory drugs against human colon cancer cells. Cancer Epidemiol Biomarkers Prev 3:433-438, 1994.
63. Alberts DS, Hixson L, Ahnen D, Bogert C, Einspahr J, Paranka N, Brendel K, Gross PH, Pamukcu R, Burt RW. Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase? J Cell Biochem 22:18-23, 1995.
64. Thompson HJ, Briggs S, Paranka NS, Piazza GA, Brendel K, Gross PH, Sperl GJ, Pamukcu R, Ahnen DJ. Inhibition of mammary carcinogenesis in rats by the sulfone metabolite of sulindac. J Natl Cancer Inst 16:1259-1260, 1995.
65. Piazza Ga, Kulchak Rahm AL, Krutzsch M, Sperl G, Paranka NS, Gross PH, Brendel K, Burt RW, Alberts DS, Pamukcu R, Ahnen DJ. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res 55:3110-3116, 1995.
66. Rao CV, Rivenson A, Simi B, Zang E, Kellogg G, Steele V, Reddy BS. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res 55:1464-1472, 1995.
67. Boolbol SK, Dannenberg AJ, Chadburn A, Martucci C, Guo XJ, Ramonetti JT, Abreu-Goris M, Newmark HL, Lipkin ML, DeCosse JJ, Bertagnolli MM. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res 56:2556-2560, 1996.
68. Furstenberger G, Gross M, Marks F. Eicosanoids and multistage carcinogenesis in NMRI mouse skin: Role of prostaglandins E and F in conversion (first stage of tumor promotion) and promotion (second stage of tumor promotion). Carcinogenesis (Lond) 10:91-96, 1989.
69. Fischer SM, Baldwin JK, Jasheway DW, Patrick KE, Cameron GS. Phorbol ester induction of 8-lipoxygenase in inbred SENCAR(SSIN) but not C57BL/6J mice correlated with hyperplasia, edema, and oxidant generation but not ornithine decarboxylase induction. Cancer Res 48:658-664, 1988.
70. Nakadate T, Aziu E, Yamamoto S, Kato R. Some properties of lipoxygenase activities in cytosol and microsomal fractions of mouse epidermal homogenate. Prostaglandins Leukot Med 21:305-319, 1986.
71. Gschwendt M, Furstenberger G, Kittstein W, Besemfelder E, Hull WE, Hagedorn H, Opferkuch HJ, Marks F. Generation of the arachidonic acid metabolite 8-HETE by extracts of mouse skin treated with phorbol ester in vivo: identification by H-NMR and GC-MS spectroscopy. Carcinogenesis (Lond) 7:449-455, 1986.
72. Fischer SM, Gleason GL, Hardin LG, Bohrman JS, Slaga TJ. Prostaglandin modulation of phorbol ester skin tumor promotion. Carcinogenesis 1:245-248, 1980.
73. 3-induced differentiation in human promyelocytic leukemia HL-60 cells. Oncol Res 9:19-28, 1997.
74. 3-Relationship to NF-κB. Oncol Res 9:31-39, 1997.
75. Chang RL, Huang M-T, Wood AH, Wong C-Q, Newmark HL, Yagi H, Sayer JM, Jerina DM, Conney AH. Effect of ellagic acid and hydroxylated flavonoids on the tumorigenicity of benzo[a]pyrene and (±)-7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10- tetrahydrobenzo[a]pyrene on mouse skin and in the newborn mouse. Carcinogenesis 6:1127-1133, 1985.
76. Khan WA, Wang ZY, Athar M, Bickers DR, Mukhtar H. Inhibition of the skin tumorigenicity of (±)-7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10- tetrahydrobenzo[a]pyrene by tannic acid, green tea polyphenols and quercetin in Sencar mice. Cancer Lett 42:7-12, 1988.
77. Jain AK, Shimoi K, Nakamura Y, Kada T, Hara Y, Tomita I. Crude tea extracts decrease the mutagenic activity of N-methyl-N′-nitro-N-nitrosoguanidine in vitro and in intragastric tract of rats. Mut Res 210:1-8, 1989.
78. Yoshizawa S, Horiuchi T, Fujiki H, Yoshida T, Okuda T, Sugimura T. Antitumor promoting activity of (-)-epigallocatechin gallate, the main constituent of "tannin" in green tea. Phytother Res 1:44-47, 1987.
79. Yang CS, Wang ZY. Tea and Cancer. J Natl Cancer Inst 85:1038-1049, 1993.
80. Katiyar SK, Mukhtar H. Tea in chemoprevention of cancer: Epidemiologic and experimental studies. (review) Int J Oncol 8:221-238, 1996.
81. Han C, Xu Y. The effect of Chinese tea on the occurrence of esophageal tumors induced by N-nitrosomethylbenzylamine in rats. Biomed Environ Sci 3:35-42, 1990.
82. Wang ZY, Wang L-D, Lee M-R, Li H, Shi ST, Ho C-T, Huang M-T, Conney AH, Yang CS. Inhibition of N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats by green tea and black tea. Carcinogenesis 16:2143-2148, 1995.
83. Wang ZY, Rajesh A, Khan WA, Mukhtar H. Protection against benzo[a]pyrene and N-nitrosodiethylamine-induced lung and forestomach tumorigenesis in A/J mice by water extracts of green tea and licorice. Carcinogenesis 13:1491-1494, 1992.
84. Wang ZY, Hong J-Y, Huang M-T, Reuhl KR, Conney AH, Yang CS. Inhibition of N-nitrosodiethylamine- and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mice by green tea and black tea. Cancer Res 52:1943-1947, 1992.
85. Katiyar SK, Agarwal R, Zaim MT, Mukhtar H. Protection against N-nitrosodiethylamine and benzo[a]pyrene-induced forestomach and lung tumorigenesis in A/J mice by green tea. Carcinogenesis 14:849-855, 1993.
86. Yamane T, Takahashi T, Kuwata K, Oya K, Inagake M, Kitao Y, Suganuma M, Fujiki H. Inhibition of N-methyl-N′-nitro-N-nitrosoguanidine-induced carcinogenesis by (-)-epigallocatechin gallate in the rat glandular stomach. Cancer Res 55:2081-2084, 1995.
87. Fujita Y, Yamane T, Tanaka M, Kuwata K, Okuzumi J, Takahashi T, Fujiki H, Okuda T. Inhibitory effect of (-)-epigallocatechin gallate on carcinogenesis with N-ethyl-N′-nitro-N-nitrosoguanidine in mouse duodenum. Jpn J Cancer Res 80:503-505, 1989.
88. Ito N, Hirose M, Shiral T. Carcinogenicity and modification of carcinogenic response by plant phenols. In: Huang M-T, Lee CY, Ho C-T, Eds. Phenolic Compounds in Foods and Health, II. Antioxidants and Cancer Prevention. Washington, DC: American Chemical Society, pp 269-281, 1992.
89. Yamane T, Hagiwara N, Tateishi M, Akachi S, Kim M, Okuzumi J, Kitao Y, Inagake M, Kuwata L, Takahashi T. Inhibition of azoxymethane-induced colon carcinogenesis in rat by green tea polyphenol fraction. Jpn J Cancer Res 82:1336-1339, 1991.
90. Yin P, Zhao J, Cheng S, Zhu Q, Liu Z, Zhengguo L. Experimental studies of the inhibitory effects of green tea catechin on mice large intestinal cancers induced by 1,2-dimethylhydrazine. Cancer Lett 79:33-38, 1994.
91. Xu Y, Ho C-T, Amin SG, Han C, Chung F-L. Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants. Cancer Res 52:3875-3879, 1992.
92. Shi ST, Wang ZY, Smith T, Hong J-Y, Chen W-F, Ho C-T, Yang CS. Effects of green tea and black tea on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone bioactivation, DNA methylation, and lung tumorigenesis in A/J mice. Cancer Res 54:4641-4647, 1994.
93. Luo SQ, Liu XZ, Wang CJ. Inhibitory effect of green tea extract on the carcinogenesis induced by asbestos plus benzo[a]pyrene in rat. Biomed Environ Sci 8:54-58, 1995.
94. Hara Y. Prophylactic functions of tea polyphenols. In: Yamanishi T, Ed. Proceedings of the International Symposium on Tea Science. Shizuoka, Japan: Kurofune Printing Co. Ltd., pp22-39, 1991.
95. Harada N, Takabayashi F, Oguni I, Hara Y. Anti-promotion effect of green tea extracts on pancreatic cancer in golden hamster induced by N-nitroso-bis(2-oxopropyl)amine. In: Yamanishi T, Ed. Proceedings of the International Symposium on Tea Science. Shizuoka, Japan: Kurofune Printing Co. Ltd., pp200-204, 1991.
96. Nishida H, Omori M, Fukutomi Y, Ninomiya M, Nishiwaki S, Suganuma M, Moriwaki H, Muto Y. Inhibitory effects of (-)-epigallocatechin gallate on spontaneous hepatoma in C3H/HeNCrj mice and human hepatoma-derived PLC/PRF/5 cells. Jpn J Cancer Res 85:221-225, 1994.
97. Wang ZY, Huang M-T, Lou Y-R, Xie J-G, Reuhl K, Newmark HL, Ho C-T, Yang CS, Conney AH. Inhibitory effects of black tea, green tea, decaffeinated black tea, and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12-dimethylbenz[a]anthracene-initiated SKH-1 mice. Cancer Res 54:3428-3435, 1994.
98. Huang M-T, Xie J-G, Wang Z-Y, Ho C-T, Lou Y-R, Wang C-X, Hard GC, Conney AH. Effects of tea, decaffeinated tea, and caffeine on UVB light-induced complete carcinogenesis in SKH-1 mice: Demonstration of caffeine as a biologically important constituent of tea. Cancer Res 57:2623-2629, 1997.
99. Wang ZY, Huang M-T, Ferraro T, Wong C-Q, Lou Y-R, Reuhl K, Iatropoulos M, Yang CS, Conney AH. Inhibitory effect of green tea in the drinking water on tumorigenesis by ultraviolet light and 12-O-tetradecanoylphorbol-13-acetate in the skin of SKH-1 mice. Cancer Res 52:1162-1170, 1992.
100. Wang ZY, Huang M-T, Ho C-T, Chang R, Ma W, Ferraro T, Reuhl KR, Yang CS, Conney AH. Inhibitory effect of green tea on the growth of established skin papillomas in mice. Cancer Res 52:6657-6665, 1992.
101. Lu Y-P, Lou Y-R, Xie J-G, Yen P, Huang M-T, Conney AH. Inhibitory effect of black tea on the growth of established skin tumors in mice: Effects on tumor size, apoptosis, mitosis and bromodeoxyuridine incorporation into DNA. Carcinogenesis (in press), 1997.
102. Liao S, Umekita Y, Guo J, Kokontis JM, Hiipakka RA. Growth inhibition and regression of human prostate and breast tumors in athymic mice by daily tea epigallocatechin gallate. Cancer Lett 96:239-243, 1995.
103. Goldbohm RA, Hertog MG, Brants HA, van Poppel G, van der Brandt PA. Consumption of black tea and cancer risk, a prospective cohort study. J Natl Cancer Inst 88:93-100, 1996.
104. Blot WJ, Chow W-H, McLaughlin JK. Tea and cancer: A review of the epidemiologic evidence. Eur J Cancer Prev 5:425-438, 1997.
105. Williams GM. Modulation of chemical carcinogenesis by xenobiotics. Fund Appl Toxicol 4:325-344, 1984.
106. Verma AK, Shapas BG, Rice HM, Boutwell RK. Correlation of the inhibition by retinoids of tumor promoter-induced mouse epidermal omithine decarboxylase activity and of skin tumor promotion. Cancer Res 39:419-423, 1979.
107. 3 inhibits phorbol ester-dependent chemical carcinogenesis in mouse skin. Biochem Biphys Res Commun 116:605-611, 1983.
108. Verma AK, Conrad EA, Boutwell RK. Differential effects of retinoic acid and 7,8-benzoflavone on the induction of mouse skin tumors by the complete carcinogenesis process and by the initiation-promotion regimen. Cancer Res 42:3519-3525, 1982.
109. 3 on the formation of skin tumors in mice treated chronically with 7,12-dimethylbenz[a]anthracene. Biochem Biophys Res Commun 130:924-931, 1985.
110. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, Barnhart S, Hammar S. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334:1150-1155, 1996.
111. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 330:1029-1035, 1994.
112. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger MA, LaMotte F, Gaziana JM, Ridker PM, Willett W, Peto R. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334:1145-1149, 1996.